Metabolic and molecular imaging in inflammatory arthritis.

Authors:
Noversa de Sousa R; Tascilar K; Corte G; Atzinger A; Minopoulou I and 10 more

Journal:
RMD Open

Publication Year: 2024

DOI:
10.1136/rmdopen-2023-003880

PMCID:
PMC10862311

PMID:
38341194

Journal Information

Journal Title: RMD Open

Detailed journal information not available.

Publication Details

Subject Category: Rheumatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests: MW and FK are co-inventors, together with iThera Medical (Germany), on a European Union patent application (no. EP 19 163 304.9) relating to a device and a method for analysis of optoacoustic data, an optoacoustic system and a computer program. All other authors declare no conflicts of interest."

Evidence found in paper:

"Funding: This review was supported by the Deutsche Forschungsgemeinschaft (DFG-FOR2886 PANDORA 405969122 and the CRC1181 Checkpoints for Resolution of Inflammation 261193037). Additional funding was received by the Bundesministerium für Bildung und Forschung (project MASCARA), the ERC Synergy grant 4D Nanoscope and the Emerging Fields Initiative MIRACLE of Friedrich-Alexander University Erlangen-Nürnberg. This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 101007757 (HIPPOCRATES). The JU receives support from the European Union’s Horizon 2020 research and innovation program and EFPIA. DS was supported by the 2022 GRAPPA Pilot Research Grant. GC, AA and FF are supported by the Deutsche Forschungsgemeinschaft as part of the NOTICE clinician scientist programme."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025